<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 10 Aug 2026 04:32:36 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP20.50 at Deutsche Bank</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP20.50+at+Deutsche+Bank/26893139.html</link>
   <description>Deutsche Bank analyst Kane Slutzkin raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP20.50  (from GBP19.50) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP20.50+at+Deutsche+Bank/26893139.html</guid>
   <pubDate>Mon, 10 Aug 2026 04:32:36 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP20.50 at Deutsche Bank</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP20.50+at+Deutsche+Bank/26893139.html</link>
   <description>Deutsche Bank analyst Kane Slutzkin raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP20.50  (from GBP19.50) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP20.50+at+Deutsche+Bank/26893139.html</guid>
   <pubDate>Mon, 10 Aug 2026 04:32:36 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP20.50 at Deutsche Bank</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP20.50+at+Deutsche+Bank/26893139.html</link>
   <description>Deutsche Bank analyst Kane Slutzkin raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP20.50  (from GBP19.50) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP20.50+at+Deutsche+Bank/26893139.html</guid>
   <pubDate>Mon, 10 Aug 2026 04:32:36 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP20.50 at Deutsche Bank</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP20.50+at+Deutsche+Bank/26893139.html</link>
   <description>Deutsche Bank analyst Kane Slutzkin raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP20.50  (from GBP19.50) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP20.50+at+Deutsche+Bank/26893139.html</guid>
   <pubDate>Mon, 10 Aug 2026 04:32:36 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Citi Starts Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) at Buy</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Citi+Starts+Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+at+Buy/26775394.html</link>
   <description>&lt;p&gt;Citi analyst Giang Nguyen initiates coverage on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) with a Buy rating and a price target of GBP17.00.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Citi+Starts+Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+at+Buy/26775394.html</guid>
   <pubDate>Thu, 16 Jul 2026 01:53:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Citi Starts Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) at Buy</title>
   <link>http://www.streetinsider.com/New+Coverage/Citi+Starts+Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+at+Buy/26775394.html</link>
   <description>&lt;p&gt;Citi analyst Giang Nguyen initiates coverage on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) with a Buy rating and a price target of GBP17.00.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/Citi+Starts+Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+at+Buy/26775394.html</guid>
   <pubDate>Thu, 16 Jul 2026 01:53:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Citi Starts Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) at Buy</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Citi+Starts+Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+at+Buy/26775394.html</link>
   <description>&lt;p&gt;Citi analyst Giang Nguyen initiates coverage on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) with a Buy rating and a price target of GBP17.00.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Citi+Starts+Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+at+Buy/26775394.html</guid>
   <pubDate>Thu, 16 Jul 2026 01:53:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Citi Starts Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) at Buy</title>
   <link>http://www.streetinsider.com/New+Coverage/Citi+Starts+Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+at+Buy/26775394.html</link>
   <description>&lt;p&gt;Citi analyst Giang Nguyen initiates coverage on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) with a Buy rating and a price target of GBP17.00.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/Citi+Starts+Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+at+Buy/26775394.html</guid>
   <pubDate>Thu, 16 Jul 2026 01:53:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Barclays Reiterates Underweight Rating on Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF)</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Barclays+Reiterates+Underweight+Rating+on+Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29/26674837.html</link>
   <description>&lt;p&gt;Barclays analyst James Gordon reiterated an Underweight rating and GBP13.50 price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Barclays+Reiterates+Underweight+Rating+on+Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29/26674837.html</guid>
   <pubDate>Tue, 23 Jun 2026 02:42:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Barclays Reiterates Underweight Rating on Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF)</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Barclays+Reiterates+Underweight+Rating+on+Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29/26674837.html</link>
   <description>&lt;p&gt;Barclays analyst James Gordon reiterated an Underweight rating and GBP13.50 price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Barclays+Reiterates+Underweight+Rating+on+Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29/26674837.html</guid>
   <pubDate>Tue, 23 Jun 2026 02:42:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP1,870 at Jefferies</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP1%2C870+at+Jefferies/26428373.html</link>
   <description>Jefferies analyst James Vane-Tempest raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP1,870.00  (from GBP1,850.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP1%2C870+at+Jefferies/26428373.html</guid>
   <pubDate>Tue, 05 May 2026 05:04:24 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP1,870 at Jefferies</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP1%2C870+at+Jefferies/26428373.html</link>
   <description>Jefferies analyst James Vane-Tempest raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP1,870.00  (from GBP1,850.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP1%2C870+at+Jefferies/26428373.html</guid>
   <pubDate>Tue, 05 May 2026 05:04:24 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP1,870 at Jefferies</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP1%2C870+at+Jefferies/26428373.html</link>
   <description>Jefferies analyst James Vane-Tempest raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP1,870.00  (from GBP1,850.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP1%2C870+at+Jefferies/26428373.html</guid>
   <pubDate>Tue, 05 May 2026 05:04:24 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP1,870 at Jefferies</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP1%2C870+at+Jefferies/26428373.html</link>
   <description>Jefferies analyst James Vane-Tempest raised the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP1,870.00  (from GBP1,850.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Raised+to+GBP1%2C870+at+Jefferies/26428373.html</guid>
   <pubDate>Tue, 05 May 2026 05:04:24 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP18 at Berenberg</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP18+at+Berenberg/26106164.html</link>
   <description>Berenberg analyst Victoria Lambert lowered the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP18.00  (from GBP23.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP18+at+Berenberg/26106164.html</guid>
   <pubDate>Wed, 04 Mar 2026 04:47:40 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP18 at Berenberg</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP18+at+Berenberg/26106164.html</link>
   <description>Berenberg analyst Victoria Lambert lowered the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP18.00  (from GBP23.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP18+at+Berenberg/26106164.html</guid>
   <pubDate>Wed, 04 Mar 2026 04:47:40 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP18 at Berenberg</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP18+at+Berenberg/26106164.html</link>
   <description>Berenberg analyst Victoria Lambert lowered the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP18.00  (from GBP23.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP18+at+Berenberg/26106164.html</guid>
   <pubDate>Wed, 04 Mar 2026 04:47:40 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP18 at Berenberg</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP18+at+Berenberg/26106164.html</link>
   <description>Berenberg analyst Victoria Lambert lowered the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP18.00  (from GBP23.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP18+at+Berenberg/26106164.html</guid>
   <pubDate>Wed, 04 Mar 2026 04:47:40 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP20 at JPMorgan</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP20+at+JPMorgan/26095971.html</link>
   <description>JPMorgan analyst James Gordon lowered the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP20.00  (from GBP24.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP20+at+JPMorgan/26095971.html</guid>
   <pubDate>Tue, 03 Mar 2026 06:07:29 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP20 at JPMorgan</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP20+at+JPMorgan/26095971.html</link>
   <description>JPMorgan analyst James Gordon lowered the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP20.00  (from GBP24.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP20+at+JPMorgan/26095971.html</guid>
   <pubDate>Tue, 03 Mar 2026 06:07:29 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP20 at JPMorgan</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP20+at+JPMorgan/26095971.html</link>
   <description>JPMorgan analyst James Gordon lowered the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP20.00  (from GBP24.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP20+at+JPMorgan/26095971.html</guid>
   <pubDate>Tue, 03 Mar 2026 06:07:29 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP20 at JPMorgan</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP20+at+JPMorgan/26095971.html</link>
   <description>JPMorgan analyst James Gordon lowered the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP20.00  (from GBP24.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP20+at+JPMorgan/26095971.html</guid>
   <pubDate>Tue, 03 Mar 2026 06:07:29 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP13.50 at Barclays</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP13.50+at+Barclays/26085425.html</link>
   <description>Barclays analyst James Gordon lowered the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP13.50  (from GBP16.00) while maintaining a Underweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP13.50+at+Barclays/26085425.html</guid>
   <pubDate>Mon, 02 Mar 2026 03:59:10 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP13.50 at Barclays</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP13.50+at+Barclays/26085425.html</link>
   <description>Barclays analyst James Gordon lowered the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP13.50  (from GBP16.00) while maintaining a Underweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP13.50+at+Barclays/26085425.html</guid>
   <pubDate>Mon, 02 Mar 2026 03:59:10 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
  <item>
   <title>Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP13.50 at Barclays</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP13.50+at+Barclays/26085425.html</link>
   <description>Barclays analyst James Gordon lowered the price target on Hikma Pharmaceuticals Plc (HIK:LN) (OTC: HKMPF) to GBP13.50  (from GBP16.00) while maintaining a Underweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hikma+Pharmaceuticals+Plc+%28HIK%3ALN%29+%28HKMPF%29+PT+Lowered+to+GBP13.50+at+Barclays/26085425.html</guid>
   <pubDate>Mon, 02 Mar 2026 03:59:10 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HKMPF</category>
   	  </item>
 </channel>
</rss>
